OGI
Organigram Global, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CA
$0.94
+1.73%Forward multiples
Based on analyst estimates
- P/E forward
- 29.49x
- P/E 2026E
- 2.90x
- P/E 2027E
- 43.76x
- P/E 2028E
- 20.03x
- P/S forward
- 0.59x
Trailing multiples
Trailing twelve months
- P/E TTM
- 2.10x
- PEG TTM
- —
- Price / book
- 0.34x
- Price / sales
- 0.62x
- Price / cash flow
- -6.73x
Enterprise value
- Enterprise value
- $192.8M
- EV / sales
- 0.88x
- EV / EBITDA
- 14.80x
- EV / EBIT
- -40.70x
- Market cap
- $135.9M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026